After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of ORIC Pharmaceuticals Inc is $805.41M. A total of 0.93 million shares were traded on the day, compared to an average of 1.39M shares.
In the most recent transaction, Multani Pratik S sold 10,720 shares of ORIC for 9.06 per share on Dec 16 ’25. After the transaction, the Chief Medical Officer now owns 68,149 company shares. In a previous transaction on Dec 16 ’25, Piscitelli Dominic sold 10,720 shares at 9.06 per share. ORIC shares that Chief Financial Officer owns now total 68,148.
Among the insiders who sold shares, Chacko Jacob disposed of 33,374 shares on Dec 16 ’25 at a per-share price of $9.06. This resulted in the PRESIDENT AND CEO holding 581,711 shares of ORIC after the transaction. In another insider transaction, Piscitelli Dominic bought 10,720 shares at $9.06 per share on Dec 16 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ORIC has a high of $14.93 and a low of $3.90.
As of this writing, ORIC has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.51. The company reported an EPS of -$0.51 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ORIC’s latest balance sheet shows that the firm has $236.98M in Cash & Short Term Investments as of fiscal 2021. There were $1.93M in debt and $15.15M in liabilities at the time. Its Book Value Per Share was $4.18, while its Total Shareholder’s Equity was $272.98M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORIC is Buy with a score of 4.73.
